Oracle’s Larry Ellison says AI-driven cancer vaccine could be coming soon as Donald Trump announces a $500 billion investment

Oracle Chairman Larry Ellison highlighted AI’s potential to revolutionize healthcare with early cancer detection and personalized vaccines. President Donald Trump announced a $500 billion private sector investment in AI infrastructure, involving a joint venture called Stargate by OpenAI, SoftBank, and Oracle. The initiative aims to create data centers and jobs, enhancing AI’s role in healthcare.

Read the full article here

Source: economictimes.indiatimes.com

Categories: Hem/Oncs, General Medicine News

Tweets with this article

Wafik S. El-Deiry, MD, PhD, FACP

Oracle's Larry Ellison says AI-driven cancer vaccine could be coming soon as Donald Trump announces a $500 billion investment https://t.co/2k8kU4wWAB

Unveiling disparities in cancer care: a comparative study… : Journal of Psychosocial Oncology Research and Practice

ty is often set by health care professionals’ (HCPs’) evaluation about the adequacy of services and programs to meet their patients’ needs. Thus, this study…

Cristiane D Bergerot January 22, 2025

The OncoAlert Newsletter is NOW OUT Click to Register

The OncoAlert Newsletter is now out for June 23-29, 2023

Matteo Lambertini, MD PhD January 22, 2025

Expanded Newborn Screening Using Genome Sequencing

This multisite, single-group, prospective, observational study examines the feasibility and potential impact of genomic newborn screening using dried blood spots in a racially and ethnically…

Rabi Hanna January 22, 2025

Enthusiasm for Transplant-Free Strategies for Low-Risk Relapsed Hodgkin Lymphoma

Studies show promising EFS, PFS, and OS at 3 to 8 years

Rabi Hanna January 22, 2025

Regeneratively farmed is the new buzz label on supermarket shelves – but what does it actually mean?

While regenerative agriculture might seem like a pioneering new approach, this term isn’t new. Here’s how it differs from organic.

Ash Paul January 22, 2025

Andrew Carnegie and the 19th-century ‘robber barons’ have lessons for today’s oligarchs about the responsibilities of wealth

The 19th-century industrialists were called ‘robber barons’ – but they did more to improve society than many of today’s super-rich.

Ash Paul January 22, 2025

Prognostic models for depression and post-traumatic stress disorder symptoms following traumatic brain injury: a CENTER-TBI study

Background Traumatic brain injury (TBI) is associated with an increased risk of major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). We aimed to identify…

Ash Paul January 22, 2025

Epidermal Growth Factor Receptor-Targeted Neoantigen Peptide Vaccination for the Treatment of Non-Small Cell Lung Cancer and Glioblastoma

The epidermal growth factor receptor (EGFR) plays crucial roles in several important biological functions such as embryogenesis, epithelial tissue development, and cellular regeneration. However, in…

Wafik S. El-Deiry, MD, PhD, FACP January 22, 2025

AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients

Acute myeloid leukemia (AML) has a dismal prognosis, mostly due to minimal residual disease-driven relapse, making an elimination of persisting therapy-resistant leukemia progenitor/stem cells (LPCs)…

Wafik S. El-Deiry, MD, PhD, FACP January 22, 2025

Targeting minimal residual disease (MRD) in resected RAS mutated pancreatic cancer with vaccine TG01/QS-21 +/- PD-1 inhibitor, balstilimab: A randomized phase II study (TESLA).

TPS4205 Background: MRD detected by presence of circulating tumor DNA (ctDNA) after intended curative treatment is associated with high risk of relapse in pancreatic cancer.…

Anup Kasi MD MPH January 22, 2025

Related Articles